Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioMarket CapitalizationNet MarginOperating MarginReturn on SalesTimes Interest Earned

Solid Biosciences (SLDB) Assets Average: 2018-2024

Historic Assets Average for Solid Biosciences (SLDB) over the last 7 years, with Sep 2024 value amounting to $221.4 million.

  • Solid Biosciences' Assets Average rose 13.70% to $221.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $221.4 million, marking a year-over-year increase of 13.70%. This contributed to the annual value of $212.6 million for FY2023, which is 13.69% down from last year.
  • According to the latest figures from Q3 2024, Solid Biosciences' Assets Average is $221.4 million, which was down 7.69% from $239.8 million recorded in Q2 2024.
  • Solid Biosciences' 5-year Assets Average high stood at $275.6 million for Q2 2021, and its period low was $49.2 million during Q3 2020.
  • For the 3-year period, Solid Biosciences' Assets Average averaged around $213.3 million, with its median value being $217.2 million (2023).
  • In the last 5 years, Solid Biosciences' Assets Average slumped by 56.66% in 2020 and then surged by 422.78% in 2021.
  • Over the past 5 years, Solid Biosciences' Assets Average (Quarterly) stood at $105.8 million in 2020, then spiked by 127.40% to $240.7 million in 2021, then dropped by 7.61% to $222.4 million in 2022, then decreased by 21.37% to $174.8 million in 2023, then climbed by 13.70% to $221.4 million in 2024.
  • Its Assets Average stands at $221.4 million for Q3 2024, versus $239.8 million for Q2 2024 and $206.8 million for Q1 2024.